
    
      To assess the oral mucosal health associated with 3 weeks of use of test product, Nicotine
      Bitartrate 4 mg mint lozenge, relative to a reference product, Nicorette® [Nicotine
      Polacrilex] 4 mg mint lozenge, in healthy adult smokers motivated to quit smoking.

      To evaluate the safety and tolerability of Nicotine Bitartrate 4 mg mint lozenge and
      Nicorette® [Nicotine Polacrilex] 4 mg mint lozenge in this subject population.
    
  